Tissue-specific MR contrast agents
- 1 April 2003
- journal article
- review article
- Published by Elsevier in European Journal of Radiology
- Vol. 46 (1) , 33-44
- https://doi.org/10.1016/s0720-048x(02)00332-7
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- Effects of Prolonged Intensive Lipid-Lowering Therapy on the Characteristics of Carotid Atherosclerotic Plaques In Vivo by MRIArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinomaJournal of Magnetic Resonance Imaging, 1999
- Detection and characterization of primary liver cancer in rats by MS‐264‐enhanced MRIMagnetic Resonance in Medicine, 1996
- Polymetallic macromolecules are potential contrast agents of improved efficiencyMagnetic Resonance in Medicine, 1994
- Mion-ASF: Biokinetics of an MR receptor agentMagnetic Resonance Imaging, 1993
- Biodistribution and Clearance of Liposomal Gadolinium-DTPAInvestigative Radiology, 1990
- Iron-EHPG as an Hepatobiliary MR Contrast AgentJournal of Computer Assisted Tomography, 1985
- CT Evaluation of Hepatic and Splenic Trauma with EOE-13Investigative Radiology, 1985
- Autoradiography of Manganese: Accumulation and Retention in the PancreasActa Pharmacologica et Toxicologica, 1983